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Methods: In a blinded experiment, genetically diabetic and wildtype control mice (each 
n=20) were transfected with recombinant adenoviruses encoding the ligand-bindlng 
@&domain of VEGF type 2 receptor Flk-1 @IO) or cDNA encoding the murine IgGPa 
Fc fragment (control). Five days after gene transfer two full thickness skin wounds 
(0.8cm) were created on the dorsum of each mice. Wound closure was measured over 9. 
14 days after which wounds were resected for histological analysis. Prior to sacrifice flu- 
orescent microspheres were systemically injected for quantitation of wound vascularity. 
Results: In diabetic mice wound healing was markedly impaired compared to control 
mice (pcO.001). Although differences were small, single I.“. injections of viruses encod- 
ing soluble Flk-1 significantly attenuated wound closure compared to Fc treated animals 
in both diabetic and non-diabetic mice (p<O.O5). Fluorescence microscopy revealed a 2.9 
fold (diabetic) and 2.0 fold (non-diabetic) reduction in wound vascularity in Flk-1 treated 
animals (p<O.O5). Impairment of angiogenesis was confirmed by CD31 immunohis- 
tochemistry. Conclusion: Adenoviral gene transfer with the soluble VEGF receptor Flk-1 
inhibits wound angiogenesis and delays wound closure in a murine excisional wound 
model. 
Conclusion: Heterotopic transplantation of endothelial cell within a fibrin matrix enhances 
neovascularization, increases myocardial blood flow, and improves left ventricular func- 
tion. 
1201-121 Hypoxia Upregulates Expression of Periostin, a Novel 
Extracellular Matrix Protein, in Rat Lung via PI3 Kinase- 
MAP Kinase Signaling Pathway 
&&i, Suzanne Oparil. Yiu-Fai Chen, University of Alabama at Birmingham, 
Birmingham. AL 
Peroistin, a novel extracellular matrix protein, is expressed in osteoblasts or osteoblast- 
like cell lines. This study tested the hypothesis that periostin is increased in rat lung and 
in isolated pulmonary arterial smooth muscle cells (PASMCs) in response to the stress of 
hypoxia and explored the signaling pathway involved. Sprague Dawley rats were 
exposed to hypoxia (10% Q) or normoxia (21% Q) for 2 wks; growth-arrested rat 
PASMCs were incubated under hypoxia (1% Q) for 24hrs. Hypoxia increased periostin 
expression P-fold in lung and 1.8-fold in PASMCs, by Northern analysis. The expression 
of periostin in PASMCs was stimulated by the treatment (24hrs) with hypoxia-responsive 
growth factors, FGF-1, PDGF-BB, endothelin-l(ET-I). anglotensin II(All), and the 
increases were blocked by the receptor tyrosine kin&e inhibitors (PD166866 for FGF-I, 
AG1295 for PDGF-BB) or receptor antagonists (bosentan for ET-l, losartan for All), or by 
PI3 kinase inhibitors (LY294002 or Wortmannin) or MAP kinase inhibitor (UO126) or DNA 
transcription inhibitor (actinomycin D). but not by PKC inhibitor (Calphostin C) or PKA 
inhibitor (H-89) or adenylate cyclase inhibitor (SQ22536). These data provided the first 
evidence that hypoxia, alone or through hypoxia-responsive growth factors, upregulates 
periostin expression in rat lung by a transcriptional mechanism, via PI3 kinase_MAP 
kinase signaling pathway. Current findings suggest vascular periostin may play a role in 
hypoxia induced pulmonary vascular remodeling. 
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1201-122 Transplantation of Autologous Endothelial Cells 
Induces Angiogenesis in a Sheep Model of Chronic 
lschemia 
Nicholas N. Kipshidze, Guennady Tchekanov. George Dangas, Roxana Mehran, Fermin 
Tio. Garv S. Roubin. Milena G. Adamian. Martin B. Leon. Antonio Colombo. Elazer 
Edelman, Jeffrey W: Moses, Masood Akhtar, Valeri Chekanov, Lenox Hill tieart and 
Vascular Institute, Cardiovascular Research Foundation, New York, NY, Heart Care 
Associates and Milwaukee Heart Institute, Milwaukee, WI 
Objective: The objective of the study was to investigate the feasibility and efficacy of 
autologous endothellal cell transplantation “sing a fibrin matrix in the ischemic myocar- 
dium of sheep. 
Methods: Four weeks after placing an ameroid constrictor in the second branch of the cir- 
cumflex artery of 24 adult sheep, six animals (EC-group) were subjected to endothelial 
cell transplantation. In 6 (saline group) saline with added inactivated cells were injected, 
in other 6 (fibrin group) fibrin sealant was injected, and 6 animals served as control. Eight 
weeks after treatment the animals were sacrificed to assess myocardial blood flow, left 
ventricular function, and neovascularization were evaluated. 
Results: Eight weeks after injection. ventricular function was markedly improved in the 
EC transplant and fibrin groups, but had deteriorated in the saline and control groups. 
Myocardial blood flow was also increased in the EC-group. Histology and electron 
microscopy revealed extensive neovascularization after endothelial cell transplantation 
and improved myocardial appearance. 
1201-152 Angiogenic Potential of Subcutaneous Adipose Stromal 
Cells for Autologous Cell Therapy 
Jalees Rehman, Jingling Li. Catharine A. Williams, Jason E. Bovenkerk, Robert V. 
Considine, Keith L. March, Indiana University, School of Medicine, Indianapolls, IN 
Background: The delivery of autologous pluripotent cells to increase angiogenesis is 
emerging as a novel treatment option for patients with coronary artery disease. Autolo- 
gous delivery of such cells is limited by the fact that the required cell numbers often 
exceed the number of available pluripotent cells. It has recently been shown that the sub- 
cutaneous adipose tissue contains large numbers of pluripotent stem cells in the non-adi- 
pocyte stromal fraction and may thus be a source for autologous delivery. We therefore 
examined the angiogenic potential of adipose stromal cells. 
Methods: Subcutaneous adipose tissue biopsies were obtained from obese volunteers. 
The stromal fraction was separated from the adipocyte fraction by centrifugation and cul- 
tured. Conditioned media was assayed after 72 hours for Vascular Endothelial Growth 
Factor (VEGF), Hepatocyte Growth Factor (HGF) and Granulocyte Colony Stimulating 
Factor (G-CSF) by ELISA ; data are reported as mean pg per 10s cells f standard error 
of mean. The ability of adipose stromal cells to form tubes in vitro was evaluated using a 
MatrigelTM assay. Transfectability of the adipose stromal cells was assessed using Green 
Fluorescent Protein (GFP) plasmid to determine whether the cells could be used as 
autologo”s cell vectors. 
Results: Subcutaneous adipose stromal cells secreted 10297 f 4724 pg / 10s cells of 
VEGF, 6698 f 3459 pg / 106cells of HGF and 976 * 439 pg / IO” cells of G-CSF over a 
period of 72 hours. These cells manifest greater than 50% transfection with pGFP follow- 
ing electroporation. Adipose stromal cells were able to form cord-like structures in the 
MatrigelTM assay similar to those formed by endothelial cells. 
Conclusions: Our experiments delineate the angiogenic potential of the easily accessi- 
ble subcutaneous adipose stromal cells by demonstrating the secretion of multiple syner- 
gistically acting pro-angiogenic growth factors, in vitro tube or cord formation and 
successful transfection with a plasmid. These findings suggest that autologous delivery 
of either native or transduced subcutaneous adipose stromal cells may be a novel thera- 
peutic option to enhance angiogenesis. 
1201-153 Tumor Necrosis Factor Signaling Not Important for 
Arteriogenesis but for Angiogenesis 
Armin Helisch, Shawn Wagner. Antje Willuweit. Wulf Ito. Matthias Clauss, Wolfgang 
Schaoer. Max-Planck-Institute for Phvsiol. &Clinical Research, Bad Nauheim. German”. 
University Hospital Hamburg-Eppendorf, Hamburg, Germany 
_. 
Background: The restoration of flow after femoral artery (FA) occlusion in mice is pre- 
dominantly due to the growth of proximal collateral arteries (arieriogenesis). Tumor 
Necrosis Factor (TNF) a is a cylokine that has been found to be expressed by macroph- 
ages around growing collateral arteries and capillaries. There are conflicting reports 
about the role of TNF in angiogenesis in viva and one study suggested that TNF signal- 
ing is important for arteriogenesis in mice. 
Methods: We performed right FA ligations in rats, C57BU6 mice (Wl)(n=lO), TNF 
Receptor 1 (TNFRl)-/- (n=lO), TNFR2-I- (n=lO), and TNFa -/- mice (n=6)(backcrossed 
to C57BLl6 background). Furthermore, we studied WT mice (n=6) and littermates with 
endothelial-specific overexpression of a membrane-spanning precursor of TNF 
(tmTNF)(n=lO). In rats immunofluorescent staining on growing collaterals with an anti- 
body specific for tmTNF was performed. Mice were serially examined up to 21 days after 
surgery, perfusion was measured by laser Doppler imaging, hemoglobin oxygenation by 
transcutaneous spectrometty, and calf blood flow by MRI (MFtflow). As angiogenesis 
assay, subcutaneous matrigel plugs (containing FGF-2 and VEGF) were implanted in 
mice endothelial tmTNF overexpressing mice(n=6) and controls (n=7); capillaries stain- 
ing positive for CD31 were counted in the matrigel plugs 14 days after implantation 
(blinded). 
Results: Already 12 hours after arterial occlusion tmTNF was expressed by endothelial 
cells in growing rat collateral arteries, but not on the non-ligated side. However, there 
were no significant differences in relative (right-to-left ratio) hindlimb perfusion, oxygen- 
ation, or calf blood flow between the transgeniclknock-out mice and their controls at rest. 
Capillary counts per HPF in matrigel plugs of tmTNF overexpressing mice were higher 
than in controls, 1.183*0.412 vs. 0.092*0.025 (mean&EM. p<O.Ol). 
Conclusion: TNF is expressed in the endothelium of growing collaterals and by sur- 
rounding macrophages. However our data do not suggest any significant involvement of 
TNF on arteriogenesis in a mouse hindlimb ischemia model. On the other hand, endothe- 
lial overexpression of TNF promotes angiogenesis in viva. 
